The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).
Medtronic today announced the official launch of its CD Horizon ModuLeX spinal system for deformity procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback